Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for early acute severe hepatitis B or HBV-related acute-on-chronic liver failure
ChiCTR-TRC-12002741Phase 4Recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylprednisolone in Acute hepatitis B and acute-on-chronic liver failure (ACLF) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Survival rate. Started Jul 2011; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
Acute hepatitis Bacute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on ChiCTR-TRC-12002741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002741.